This review highlights progress in disease resistance genes and molecular breeding technologies for Musa spp., indicating new strategies for enhanced resilience.
Banana (Musa spp.), the fourth most important staple crop and a vital economic commodity globally, faces severe threats from Fusarium wilt tropical race 4 (TR4), leaf spot diseases, and viral infections. TR4 has spread to 25 countries, endangering 50% of banana cultivation areas. This review systematically summarizes recent advances in disease resistance gene exploration and molecular breeding technologies: (1) Functional studies of resistance genes reveal that NBS-LRR-type genes recognize pathogen effectors to activate immune responses. Overexpression of RGA2 enhances TR4 resistance in Cavendish bananas by up to 82%. (2) Precise editing of signaling regulatory genes and physical barrier-related genes significantly improves disease resistance. CRISPR-mediated editing of the MaNPR1 promoter triples TR4 resistance. (3) Breakthroughs in molecular breeding—including gene editing (CRISPR/Cas9), synthetic biology (inducible resistance circuits), and marker-assisted selection (MaACS markers)—have shortened breeding cycles from 15 to 8 years while enabling pyramiding of multi-gene resistance. However, challenges persist, such as genetic uniformity, pathogen co-evolution, and technological implementation barriers. Future efforts should integrate multi-omics technologies, develop broad-spectrum resistance strategies, and establish global germplasm innovation platforms to ensure sustainable banana production.
No takes yet. Share an insight, caveat, or question.
Fuxin Liu (2025) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: